Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on April 10, 2025

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors

Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company’s commitment to advancing Jankistomig, a one-of-a-kind PD-1/VEGFR2 dual paratopic …

Byrna Technologies Fiscal First Quarter 2025 Results

Byrna Technologies Fiscal First Quarter 2025 Results

ANDOVER, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security …

Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China

Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China

FREEHOLD, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, announced today that it has been …

Cerence AI Honored with HARMAN's Best Technology Award

Cerence AI Honored with HARMAN's Best Technology Award

BURLINGTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that it has been awarded the Best Technology Award by HARMAN during its …

Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

A$5.0 million commitment received from Australian-based private investor A$10.8 million Entitlement Offer at the same offer price as the placement Funds to support Phase III Topical clinical trials in Indonesia and Australia – catalysts for revenue in 2026 …

NevGold Discovers More Significant Oxide Gold-Antimony Results:  1.70 g/t AuEq Over 169.2 Meters (0.89 g/t Au And 0.18% Antimony), Including 2.85 g/t AuEq Over 54.4 Meters (2.26 g/t Au And 0.13% Antimony), and Also Including 13.15 g/t AuEq Over 3.1…

NevGold Discovers More Significant Oxide Gold-Antimony Results: 1.70 g/t AuEq Over 169.2 Meters (0.89 g/t Au And 0.18% Antimony), Including 2.85 g/t AuEq Over 54.4 Meters (2.26 g/t Au And 0.13% Antimony), and Also Including 13.15 g/t AuEq Over 3.1…

Vancouver, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has discovered further significant oxide gold-antimony (“Antimony”, “Sb”) …

Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025

Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, April 10, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, …

Zscaler ThreatLabz 2025 VPN Risk Report: Over Half of Organizations Say Security and Compliance Risks Make VPNs Obsolete

Zscaler ThreatLabz 2025 VPN Risk Report: Over Half of Organizations Say Security and Compliance Risks Make VPNs Obsolete

Key Findings: 92% of organizations are concerned about ransomware attacks due to VPN vulnerabilities 93% of organizations fear backdoor vulnerabilities from third-party VPN connections 81% of organizations are adopting or planning to adopt zero trust …

Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting

Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting

BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an event and …

ZenaTech Closes Miller Land Surveying Corporation, a Third Southeast Acquisition and a Fourth Nationally for the Drone as Service (DaaS) Rollout

ZenaTech Closes Miller Land Surveying Corporation, a Third Southeast Acquisition and a Fourth Nationally for the Drone as Service (DaaS) Rollout

VANCOUVER, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone-as-a-Service (DaaS), enterprise SaaS and …

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

– Clinically Meaningful Efficacy Observed on Multiple Assessments – – Confirmed Target Engagement with Reduced Iron Signal in MSA Affected Brain Regions – MELBOURNE, Australia and SAN FRANCISCO, April 10, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX …

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025

BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company developing specialty therapies for community care and public health challenges, today announced that data from several new studies of NUZYRA® …

HPQ Silicon and Novacium Sign MOU with GLD Alloys to produce Green Hydrogen with METAGENE™

HPQ Silicon and Novacium Sign MOU with GLD Alloys to produce Green Hydrogen with METAGENE™

MONTREAL and LYON France, April 10, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in green engineering processes, along with its French subsidiary NOVACIUM SAS (“ …

HPQ Silicium et Novacium signent un protocole d’entente (MOU) avec GLD Alloys pour produire de l’hydrogène vert avec METAGENE™

HPQ Silicium et Novacium signent un protocole d’entente (MOU) avec GLD Alloys pour produire de l’hydrogène vert avec METAGENE™

MONTRÉAL et LYON, France, 10 avr. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’ingénierie verte des procédés, et sa filiales française NOVACIUM …

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

Episode Highlights a Truly Remarkable Patient Story Spanning 79 Years Video features 79-year-old Norma Coles, believed to be among the earliest individuals ever evaluated for Netherton Syndrome and is available on the company’s NETHERTON NOW website …

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American Academy …

Dragonfly Energy Wins the 2025 “Battery Technology Company of the Year” CleanTech Breakthrough Award

Dragonfly Energy Wins the 2025 “Battery Technology Company of the Year” CleanTech Breakthrough Award

Selected from thousands of nominations across 14 countries, Dragonfly Energy was named “Battery Technology Company of the Year” for its industry-leading innovations in lithium battery technology. The award highlights the Company’s patented dry electrode …

Draganfly and SafeLane Global Enter into Multi-Year Agreement with Draganfly as the Preferred Global Provider of Landmine Mapping Drones and Aerial Survey Services

Draganfly and SafeLane Global Enter into Multi-Year Agreement with Draganfly as the Preferred Global Provider of Landmine Mapping Drones and Aerial Survey Services

First Ukraine Landmine Aerial Survey Contract Underway Tampa, FL, April 10, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading developer of drone solutions and systems, today …

CRB Named Rockwell Automation EPC Partner of the Year

CRB Named Rockwell Automation EPC Partner of the Year

Kansas City, Missouri, April 10, 2025 (GLOBE NEWSWIRE) -- CRB, a leading provider of engineering, architecture, construction, consulting solutions, and control systems integration is honored to be recognized as the Rockwell Automation Engineering, …

Large Reductions in Suicide Risk, Attempts and Deaths Demonstrated by Three “Real World” Studies in Primary Care

Large Reductions in Suicide Risk, Attempts and Deaths Demonstrated by Three “Real World” Studies in Primary Care

NORWALK, Conn., April 10, 2025 (GLOBE NEWSWIRE) -- The suicide rate in the US was at a more than 80-year high in 2022 with a leveling at this higher rate in the past three years. And a large majority of patients who die by suicide have visited a primary …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service